Mode
Text Size
Log in / Sign up
N/A Completed N=32 Treatment

Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study

Self-hypnosis · Functional Bowel Disorder · Functional Abdominal Pain Syndrome
Source: ClinicalTrials.gov NCT06493097 ↗
Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcomePrimary: Peds-QL-gastro — 49.91; 60.15 units on a scale

Summary

This study aims at testing the effect and feasibility of a new treatment strategy - hypnotherapy mediated with audio files - for children and adolescents with disorders of gut-brain-interaction (DGBI) in Sweden. The treatment protocol has been used and studied in Netherlands, but the investigators have translated and formed it to suit the Swedish population. This study is a feasibility study that is followed by a large RCT to compare different psychological treatment options for this patient group. If hypnotherapy mediated via audio files proves to be effective and feasible for this patient group, it would mean: 1. An exponential increase in the availability of evidence-based treatments. The hypnotherapy treatment is markedly easier to distribute than e.g. cognitive behavior therapy (CBT) which requires chat contact with a psychologist and is made available regardless of where in Sweden the family lives. In addition to shortened waiting times for patients, this would decrease the pressure in somatic care. 2. Possibility to offer tailored treatments. No treatment works for everyone. It is reasonable to assume that treatments with such different focuses as hypnotherapy and exposure-based CBT may be differently effective for different patients. A new treatment option can help a larger proportion of patients. 3. A more cost-effective treatment. Gut-directed hypnotherapy with audio files is a very inexpensive treatment, which would likely result in significant cost savings for this patient population.

Outcome Measures

OutcomeResultp-value
PRIMARY
Peds-QL-gastro
49.91; 60.15
SECONDARY
Pain Frequency and Intensity
5.69; 4.54
SECONDARY
Stress
15.78; 19.4
SECONDARY
Gastrointestinal Symtom -Related Anxiety
35.59; 35.65
SECONDARY
GI Symptom Specific Anxiety
17.38; 6.56
SECONDARY
Quality of Life
70.48; 73.54
SECONDARY
Adequate Relief
4.12

Eligibility Criteria

Inclusion Criteria

  • Diagnosis: irritable bowel syndrome, functional abdominal pain, functional dyspepsia (following the Rome IV diagnostic criteria)
  • The participant and at least one of the parents must understand Swedish

Exclusion Criteria

  • other medical condition that better explains the symtoms
  • Absence from school >40% and/or psychiatric diagnosis that is judged to be more primary than the gastrointestinal problems, in these cases the children/young people are judged to need more intensive and multi-professional treatment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06493097). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search